| Abstrakt: |
A study conducted by the University of Saskatchewan in Canada examined the outcomes of elderly patients with stage III colon cancer. The study found that patients who received adjuvant chemotherapy had significantly better overall survival (OS) and disease-free survival (DFS) compared to those who did not receive chemotherapy. Other factors associated with inferior outcomes included poor performance status, T4 or N2 disease, grade III tumor, elevated baseline CEA, past history of a secondary cancer, elevated NPNH ratio >0.1, and ostomy formation. These findings highlight the importance of adjuvant chemotherapy and other clinical factors in improving outcomes for elderly patients with stage III colon cancer. [Extracted from the article] |
